0001398659-23-000039.txt : 20231206 0001398659-23-000039.hdr.sgml : 20231206 20231206161634 ACCESSION NUMBER: 0001398659-23-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231204 FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stein Kathryn Vanpelt CENTRAL INDEX KEY: 0001806002 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33626 FILM NUMBER: 231469798 MAIL ADDRESS: STREET 1: 40 WEST 24TH STREET STREET 2: APT 3N CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Genpact LTD CENTRAL INDEX KEY: 0001398659 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 980533350 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 BUSINESS PHONE: 4412952244 MAIL ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 4 1 wk-form4_1701897384.xml FORM 4 X0508 4 2023-12-04 0 0001398659 Genpact LTD G 0001806002 Stein Kathryn Vanpelt C/O GENPACT LLC FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10175 0 1 0 0 Senior Vice President 0 Common Shares 2023-12-04 4 M 0 39050 27.70 A 143111 D Common Shares 2023-12-04 4 S 0 39050 34.8501 D 104061 D Common Shares 2023-12-04 4 S 0 18286 34.8492 D 85775 D Employee Stock Option (Right to Buy) 27.70 2023-12-04 4 M 0 39050 0 D 2029-01-10 Common Shares 39050 84051 D Includes 213 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 17, 2023. The reporting person currently holds a total of 3,337 shares under the ESPP. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $34.66 to $35.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $34.67 to $34.99. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The option vested 50% on January 10, 2022 and the remainder will vest on January 10, 2024, subject to the reporting person's continued service through such date. /s/ Thomas D. Scholtes, as Attorney-in-fact for Kathryn Stein 2023-12-06